Last edition
News about Global Pharma
Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman with heart and kidney failure—a confluence of advances that showcase the possibility and hope of modern medicine.
Global Pharma | 25/04/2024 | By Manvi | 320
Bormioli Pharma's EcoPositive Line Achieves 45 Percent Sustainable Materials Utilization
The company has made significant strides in increasing the share of sustainable materials in its products, nearing its 50 percent target by 2025 with 45 percent achieved in 2023.
Global Pharma | 25/04/2024 | By Abha | 736
Tetra Pharm Technologies and Glysious to Develop Transdermal Combination Drugs
Tetra Pharm Technologies has joined forces with Glysious, to develop a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates.
Global Pharma | 25/04/2024 | By Aishwarya | 662
Lupin Lyfe Platform Secures Class C Medical Device License from CDSCO
Lupin Digital Health has announced that its Lyfe platform has received approval as a Class C Medical Device from the Central Drugs Standard Control Organization (CDSCO).
Global Pharma | 25/04/2024 | By Aishwarya | 704
PRISM BioLab and Ono Pharmaceutical Enters into Joint Research and Licensing Agreement
Under the terms of the agreement, PRISM and Ono will collaborate closely to create a development candidate for Ono's oncology target, harnessing the cutting-edge PepMetics® technology pioneered by PRISM.
Global Pharma | 25/04/2024 | By Abha | 384
Evotec OAI Partners with Taisho Pharmaceutical to Accelerate Drug Discovery
Evotec OAI has entered into a drug discovery collaboration with Taisho Pharmaceutical Co., Ltd. Tokyo, Japan.
Global Pharma | 25/04/2024 | By Aishwarya | 579
Nordic Bioproducts Group Launches its Production Facility for Advanced Cellulosic Materials
Nordic Bioproducts Group (NBG), a leader in biomaterial innovation and developer of proprietary AaltoCell Technology, has opened its commercial-scale production facility for microcrystalline cellulose (MCC).
Global Pharma | 25/04/2024 | By Aishwarya | 528
USFDA Approves ImmunityBio Bladder Cancer Therapy
The United States Food and Drug Administration (USFDA) has approved ImmunityBio’s combination therapy to treat a type of bladder cancer.
Global Pharma | 24/04/2024 | By Aishwarya | 748
Sygnature Discovery Appoints New Chief Scientific Officer
Sygnature Discovery has appointed Dr. David Witty as Chief Scientific Officer (CSO) to its leadership team.
Global Pharma | 24/04/2024 | By Aishwarya | 931
analytica Anacon India and India Lab Expo 2024 Concludes Successfully
Messe Muenchen India and the Indian Analytical Instruments Association (IAIA) organized analytica Anacon India and India Lab Expo has concluded successfully with satisfied exhibitors and delighted visitors.
Global Pharma | 24/04/2024 | By Aishwarya | 1005
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy